RE:RE:RE:RE:RE:RE:RE:Still undervaluedThis was written another board earlier today. If big pharma already planned to spend over $1.5 billion on 2 of Dr. Hossein's chemical therapies... how much will they eventually spend on 6 to possibly 9 cannabinoid therapies? Look for additional therapy launches (from website) in the future for: Inflammation/Pain/ Huntington's, Epilepsy, Diabetes, Obesity, Cancer & Angiogenesis 3 Big Pharmas worth over $450 billion are committing another billion on Dr. Sazzad Hossein's original discovery, after spending over $500 million already: Teva 48 b Novartis 247b Merk 166b Dr. Sazzad Hossein's old company (XENE) traded as high as $19.28 today after a $9 IPO on November 5th. The market cap was over $200 million on its 5th trading day. The market cap almost reached CDN$ 400 million on January 9th: Market Cap USD$ 280,780,000 ($350 million CDN) Year High 23.50 Year Low 9.21 Today $19.28 "Pharmaceutical partners include Teva Genentech and Merck (through its affiliate, Essex Chemie). These collaborations have aggregately generated more than $140 million in non-equity funding to date, with the potential to provide more than $1.0 billion in future milestone payments"